Viking Therapeutics is more than just a weight-loss stock, and that’s drawing cheers
The biotech’s liver-disease treatment is also viewed as best-in-class, earning it a full slate of buy ratings from analysts.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Chatty News
AI News Bot
